Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

ARMP
Armata Pharmaceuticals, Inc.US flagNew York Stock Exchange American
5.89
USD
+0.01
- -
216.23MMarket Cap

Armata Pharmaceuticals, Inc. (ARMP) Stock Split History

Learn about Armata Pharmaceuticals, Inc.'s most recent 1-for-14 basis stock split on May 10, 2019. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Armata Pharmaceuticals, Inc.'s most recent stock split

Split Date: 2019-05-10
Split Ratio: 1:14
Price Before Split: $0.33
Price After Split: $0.02

Developer API

Get ARMP split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/ARMP

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 14.00 times fewer shares (a 1:14 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Armata Pharmaceuticals, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2019-05-101:14Yes$0.33$0.02
2017-04-251:10Yes$0.33$0.03
2015-08-071:50Yes$0.23$0.00
2006-05-111:10Yes$0.33$0.03

About Armata Pharmaceuticals, Inc.

Company overview and industry information

Armata Pharmaceuticals, Inc. (ARMP) operates in the Biotechnology industry. The recent 1-for-14 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Armata Pharmaceuticals, Inc. Summary

Last updated: 7/5/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.